Skip to content

The influence of gene variants on physiological responses to a Mediterranean diet - a nutritional genomics focus,

The influence of gene variants on gut bacteria diversity and composition, and levels of blood metabolites involved in glucose, fat and protein metabolism in healthy adults on a Mediterranean diet - a nutritional genomics focus.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000178145
Acronym
MEDGEN
Enrollment
80
Registered
2019-02-07
Start date
2019-08-05
Completion date
2021-09-02
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project is designed to determine if specific genetic sub-groups associated with metabolic disease risk benefit from a Mediterranean diet. This research may lead to personalised nutrition recommendations using genomic information to promote health. The aims of the proposed project are to: (i) Determine the influence of an 8-week Mediterranean dietary intervention on gut bacteria, levels of metabolites (involved in glucose, fat and protein metabolism) present in blood, and gene modifiers (whether genes are turned on or off) in blood. This will be compared to a person’s habitual diet (baseline results) and a general healthy eating diet following The Australian Guide to Healthy Eating (control diet). (ii) Determine the potential of key genetic variants related to metabolic disease (including the Fat Mass and Obesity-Associated (FTO) gene, Transcription Factor 7-Like 2 (TCF7L2) gene, and Apolipoprotein E (APOE) gene) to influence gut bacteria, blood metabolite and gene modifying outcomes in response to the dietary interventions. (iii) Determine whether differences between genetic variants exist for body composition, key hormones (ghrelin and insulin), glucose tolerance, and dietary intake (food frequency and nutrient composition) in response to the dietary interventions. It is hypothesized that variations in key genes associated with metabolic disease impacts on gut bacteria, blood metabolites and gene modifiers following an 8-week Mediterranean dietary intervention.

Interventions

Clinical Sessions (approximately 3 hours each): Eligible participants will be asked to attend the Clinical Trial Suites at RMIT University Bundoora (Building 203) and asked to bring the signed consent form. Participants will be asked to complete a personal information and medical questionnaire. During the initial (baseline) clinical session participants will perform a standard buccal swab (this will not be repeated in subsequent clinical sessions). Each buccal swab will be used for genetic prof

Clinical Sessions (approximately 3 hours each): Eligible participants will be asked to attend the Clinical Trial Suites at RMIT University Bundoora (Building 203) and asked to bring the signed consent form. Participants will be asked to complete a personal information and medical questionnaire. During the initial (baseline) clinical session participants will perform a standard buccal swab (this will not be repeated in subsequent clinical sessions). Each buccal swab will be used for genetic profiling using Single Nucleotide Polymorphism arrays. During the clinical session participants will be weighed, measured for height and have their hip to weight ratio recorded. Blood pressure will be measured using a sphygmomanometer. Participants will have their body composition measured using Dual-Energy X-ray Absorptiometry (DEXA). Participants will then be asked to wear a respiratory mouth piece and nose clip (for approximately 10 mins) to have their respiratory gases measured every 30 seconds via an open-circuit sampling system. Respiratory data will be used to determine resting metabolic rate and each participant’s daily energy requirements. Following this, participants will perform a standard oral glucose tolerance test (OGTT) to determine glucose handling. Blood samples will be taken prior to, at 30-mins, 60-mins and 120-mins following glucose ingestion for subsequent measure. Habitual dietary intake will be measured using a 3-day food record (2 weekdays and 1 weekend day). Participants will be asked to complete a food frequency questionnaire. Dietary quality will be assessed using the Healthy Eating Index (Basiotis et al. 2002). Mood State will be analysed using the Profile of Mood State questionnaire and the Hospital Anxiety and Depression Scale questionnaire. These questionnaires will be administered whilst the participants are undertaking the OGTT. Stool samples will be collected by participants using a stool collection kit. During the 1st and 2nd clinical session, the participant will also consult with the Accredited Practising Dietitian for approximately 45min-1hour to explain the dietary intervention phase and to collect food diaries. In the final clinical session the Accredited Practising Dietitian will also meet with the participant to collect final food diaries and food frequency questionnaires. Following the initial (baseline) clinical session participants will be eligible to commence the dietary intervention and will be randomly assigned to either the 8-week Mediterranean dietary intervention or the 8-week General Healthy Eating intervention (Control). This dietary intervention timeframe has demonstrated physiological changes on a molecular and metabolic level (Bondia-Pons et al. 2015; Marques-Rocha 2016). This study will be analysed as a parallel design. Dietary Intervention Mediterranean (8-weeks): Each participant will receive a detailed sample Mediterranean meal plan, recipes, and education material to assist with adherence to a Mediterranean diet for the 8-week period. This will be explained by an Accredited Practising Dietitian during the clinical session. This task will be facilitated by providing a calibrated scale, a menu plan to each participant, along with a food hamper with food items that will be used as part of a Mediterranean diet. Each Mediterranean meal plan will adhere to the Mediterranean diet developed in the Mediterranean Diet Model in Australia: Strategies for Translating the Traditional Mediterranean Diet into a Multicultural Setting study (George et al. 2018) and the validated protocols used in the PREDIMED trials (Martinez-Gonzalez et al. 2012). This includes using extra virgin olive oil (minimum 3-4 tablespoons per day), eating vegetables with every meal (100g leafy greens, 100g other vegetables, 100g tomatoes per day), at least two serves of fruit per day, legumes at least twice per week, at least three serves of fish per week, red meat less often, one serve of nuts daily, two serves of dairy daily (milk and yoghurt preferable), cheese in moderation (three days per week preferably feta, 1 serve equalling 30 grams), choice of wholegrain breads and cereals, consuming 3 eggs per week, sweets to be consumed in moderation (preferably homemade), red wine is optional (0-2 standard glasses per day, with meals, instructions to not get intoxicated). Advice on alcohol will be provided to those who already consume alcohol in their habitual diet. Dietary Intervention General Healthy Eating (8-weeks): Each participant will be provided with general healthy eating advice in accordance to the Australian Guide to Healthy Eating (AGTHE). This task will be facilitated by providing the participant with relevant education material, a guide to food groups and portion/serve sizes, with a focus on high fibre, low fat eating and reduced intake of discretionary foods. This diet has been chosen as a control diet based on previous literature and to also reflect current dietetic advice provided in practice to the Australian population (Papamiltiadous et al. 2016; Itsiopoulos et al. 2018). Dietary intake will be measured using a 3-day weighed food record during the intervention mid-point (week 4) and the week before the end of each dietary intervention (week 7/prior to the post intervention clinical session). Adherence to the Mediterranean diet will be assessed using the Mediterranean Diet Adherence Screener Score (MEDAs) tool. An ad libitum approach for each diet will be advised, based on previous literature (Papamiltiadous et al. 2016; Jacka et al. 2017; Itsiopoulos et al. 2011; Itsiopoulos et al. 2018; Ryan et al. 2013). The participant will consult with the Accredited Practising Dietitian during the clinical sessions for approximately 45-60 minutes. The participant will also receive weekly telephone calls to support the participant throughout the dietary intervention. Participants will be instructed to maintain their habitual physical activity patterns during the intervention, with physical activity patterns monitored and evaluated weekly by informal individual support-orientated phone calls throughout the 8-week intervention. Food recall strategies will be adopted by researchers throughout these phone calls to monitor and evaluate dietary compliance.

Sponsors

Dr. Jessica Danaher
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

Individuals with a body mass index greater than 18.5 kg/m2, males and females aged between 18 - 55 years who are deemed eligible to participate as indicated by not meeting one or more of the exclusion criterion.

Exclusion criteria

Participants will be excluded from participating within the project for the following reasons: Individuals with presence of psychiatric disorders, pathologic eating disorders, chronic diseases related to the metabolism of energy and nutrients (i.e. hyperthyroidism), difficulty in changing food habits, participants with special dietary needs (e.g. exclusion of whole food groups), and/or unable or unwilling to give informed consent. These exclusion criterion are set as they may influence an individual’s ability to comply with the recommendations of the nutritional intervention. Additional exclusion criterion includes: weight instable in the previous 3 months (evident by a loss or gain of more than 10% of total body weight), pregnant or potentially pregnant, post-menopausal, taking contraindicated mediation (e.g. antibiotics, thyroid, hyperlipidemic, hypoglycemic, hypertensives, psychotropic drugs or appetite suppressants) or the use of any dietary supplement that might interfere with the results of the study. These additional exclusion criteria are set as the may exert an independent influence on microbiome and metabolic outcomes, anthropometric, biochemical, clinical, body composition (DEXA) analysis and/or dietary outcomes monitored throughout the intervention.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026